What USP Class VI Means and Why It Matters

USP Class VI is a biocompatibility classification from the United States Pharmacopeia that focuses on a material’s biological response. It is commonly used to screen elastomers, usp class vi silicone, and class vi plastics for sanitary process connections, single-use assemblies, and medical device components with limited or transient patient contact. By meeting USP Class VI requirements, materials demonstrate that they are unlikely to cause unacceptable systemic toxicity or local irritation under specified extraction conditions.

Typical uses include sanitary gaskets, o-rings, tubing, pump diaphragms, valve seats, and seals found in filling, transfer, and filtration systems. For many teams, the designation provides a consistent baseline across suppliers and facilities, streamlining vendor qualification and validation activities.

However, usp class vi requirements do not address every performance attribute. The designation does not characterise extractables and leachables for your exact process, nor does it confirm sterilisation compatibility, long-term stability, mechanical endurance, or particulate control. Choosing a material solely because it is USP Class VI can overlook temperature and pressure limits, solvent and drug interactions, or the effects of CIP/SIP cycles. Use the designation as a starting point within a comprehensive, risk-based programme.

USP Class VI Testing: Methods and How to Read the Results

USP Class VI testing focuses on three in vivo assessments to evaluate biological reactivity:

• Systemic toxicity: Determines whether material extracts cause acute adverse effects when administered intravenously or intraperitoneally in an animal model.
• Intracutaneous reactivity: Scores local irritation following injection of extracts into the skin, monitoring erythema and edema over time.
• Implantation: Examines tissue response after subcutaneous or intramuscular placement, with histology used to assess inflammation, necrosis, or abnormal integration.

Passing results indicate no systemic toxicity at the tested dose, minimal or no irritation against controls, and acceptable tissue response at the implant site. Common reasons for failure include residual processing aids, unreacted monomers, plasticisers or additives that migrate under extraction, and insufficient curing or post-processing. Because small formulation or process changes can alter outcomes, change control and lot traceability are critical for any usp class vi silicone or class vi plastics programme.

To generate meaningful data during USP Class VI testing, follow best practices in sample preparation:

• Test production-equivalent materials with final cure cycles, surface finish, and all intended additives and colorants.
• Replicate commercial cleaning steps and document washing or conditioning procedures.
• Select extraction media and temperatures that reflect realistic worst-case conditions aligned with the method.
• Maintain full traceability for lot numbers, processing parameters, sterility state, and sample sizes for all replicates.

How USP Class VI Fits in Modern Qualification

Regulators and industry groups continue to emphasise holistic, risk-based biological evaluation. USP Class VI remains useful, but it should not stand alone. Modern workflows pair USP Class VI testing with ISO 10993 planning, toxicological risk assessments, and process-specific extractables and leachables studies. This approach reflects actual use conditions, including sterilisation (steam, gamma, EtO), temperature, contact time, and exposure to solvents, buffers, or drug formulations.

A practical framework includes:

• Developing a biological evaluation plan under ISO 10993 that considers device or process type, nature and duration of contact, and existing data.
• Mapping process and patient-contact scenarios, selecting relevant endpoints, and justifying testing through toxicological risk assessment.
• Running targeted E&L studies with representative media and worst-case parameters, then confirming that post-sterilisation extractables and mechanical properties remain acceptable.
• Leveraging supplier data packages while verifying key elements in your application. This is especially important for usp class vi silicone and class vi plastics exposed to aggressive media.

Practical Steps for Teams

Use these steps to accelerate validation while strengthening compliance:

• Use USP Class VI as an initial screen, then build a risk-based evidence package tailored to your process.
• Request full disclosure of formulation, curing chemistry, and additive packages to support ongoing USP Class VI requirements.
• Review supplier USP Class VI testing summaries and E&L data, and verify with in-house studies that reflect your CIP/SIP cycles, hold times, and sterilisation methods.
• Maintain robust documentation, including certificates of compliance, lot traceability, change notifications, and validated cleaning instructions.
• For critical uses, add ISO 10993 endpoints or deeper E&L work to close data gaps identified in your risk assessment.

How Rubber Fab Helps You Meet the Mark

Rubber Fab is a trusted partner to bioprocessing, pharmaceutical, and sanitary processing teams. Our portfolio includes sanitary gaskets, o-rings, seals, and single-use components designed for demanding service. Many of our elastomers are available as USP Class VI silicone.

Working with Rubber Fab means you get more than a compliant part. You gain application expertise that helps you select the right material, align sterilisation methods with stability, and build a risk-based package that goes beyond basic USP Class VI requirements. Our team can guide you on compatibility, temperature and pressure limits, and pathways to application-specific verification.

Whether you are standardizing on USP Class VI silicone for hygienic seals or qualifying Class VI plastics for single-use assemblies, Rubber Fab brings the data, documentation, and support you need.